Tokyo Tape
Sign in
← Nissha

Quarterly report · Q2

7915.TEDINET S100OVBF
Period2022-01-01 → 2022-06-30
Filed2022-08-10
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 52
MetricValuePeriodScopeSource row
Operating income¥6.3bn2022-01-01 → 2022-06-30Cons.Operating profit loss IFRS
Operating income¥3.8bn2022-04-01 → 2022-06-30dCons.Operating profit loss IFRS
Operating income¥10.9bn2021-01-01 → 2021-06-30Cons.Operating profit loss IFRS
Operating income¥5.5bn2021-04-01 → 2021-06-30dCons.Operating profit loss IFRS
Profit before tax¥9.5bn2022-01-01 → 2022-06-30Cons.Profit loss before tax IFRS
Profit before tax¥6.0bn2022-04-01 → 2022-06-30dCons.Profit loss before tax IFRS
Profit before tax¥19.5bn2021-01-01 → 2021-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥12.2bn2021-01-01 → 2021-06-30Cons.Profit loss before tax IFRS
Profit before tax¥6.0bn2021-04-01 → 2021-06-30dCons.Profit loss before tax IFRS
Net income (owners)¥7.9bn2022-01-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥4.6bn2022-04-01 → 2022-06-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥15.9bn2021-01-01 → 2021-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥10.6bn2021-01-01 → 2021-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥5.2bn2021-04-01 → 2021-06-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥7.9bn2022-01-01 → 2022-06-30Cons.Profit loss IFRS
Net income¥4.6bn2022-04-01 → 2022-06-30dCons.Profit loss IFRS
Net income¥10.6bn2021-01-01 → 2021-06-30Cons.Profit loss IFRS
Net income¥5.2bn2021-04-01 → 2021-06-30dCons.Profit loss IFRS
Total assets¥228.6bnat 2022-06-30Cons.Assets IFRS
Total assets¥209.3bnat 2021-12-31Cons.Assets IFRS
Total assets¥207.6bnat 2021-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥116.7bnat 2022-06-30Cons.Liabilities IFRS
Total liabilities¥111.0bnat 2021-12-31Cons.Liabilities IFRS
Net assets / equity¥111.8bnat 2022-06-30Cons.Equity IFRS
Net assets / equity¥98.3bnat 2021-12-31Cons.Equity IFRS
Net assets / equity¥94.1bnat 2021-06-30Cons.Equity IFRS
Net assets / equity¥81.9bnat 2020-12-31dCons.Equity IFRS
Equity (owners)¥111.9bnat 2022-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥98.3bnat 2021-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥94.1bnat 2021-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥45.0bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥42.3bnat 2021-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥31.9bnat 2021-06-30Cons.Cash and cash equivalents IFRS
Operating cash flow¥3.4bn2022-01-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥18.8bn2021-01-01 → 2021-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥9.1bn2021-01-01 → 2021-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥3.3bn2022-01-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥6.9bn2021-01-01 → 2021-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥3.2bn2021-01-01 → 2021-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥1.0bn2022-01-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥2.6bn2021-01-01 → 2021-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥838m2021-01-01 → 2021-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥158.622022-01-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥92.762022-04-01 → 2022-06-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥318.352021-01-01 → 2021-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥2132021-01-01 → 2021-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥104.092021-04-01 → 2021-06-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥317.162021-01-01 → 2021-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥211.42021-01-01 → 2021-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio48.9%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio47.0%at 2021-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio45.4%at 2021-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 28
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-01-01 → 2022-06-30−¥446m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30−¥212m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-06-30−¥400m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥152m
jpcrp040300-q2r_E00703-000Devicesreportable segmentsegment profit2022-01-01 → 2022-06-30¥3.7bn
jpcrp040300-q2r_E00703-000Devicesreportable segmentsegment profit2022-04-01 → 2022-06-30¥2.3bn
jpcrp040300-q2r_E00703-000Industrial Materialsreportable segmentsegment profit2022-01-01 → 2022-06-30¥3.4bn
jpcrp040300-q2r_E00703-000Industrial Materialsreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.9bn
jpcrp040300-q2r_E00703-000Medical Technologiesreportable segmentsegment profit2022-01-01 → 2022-06-30¥0
jpcrp040300-q2r_E00703-000Medical Technologiesreportable segmentsegment profit2022-04-01 → 2022-06-30−¥6m
—segment totalsegment profit2022-01-01 → 2022-06-30¥7.1bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥4.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-01-01 → 2022-06-30¥6.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥3.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-01-01 → 2021-06-30−¥538m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-06-30−¥205m
Reconciling Itemsreconcilingsegment profit2021-01-01 → 2021-06-30−¥474m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥774m
jpcrp040300-q2r_E00703-000Devicesreportable segmentsegment profit2021-01-01 → 2021-06-30¥8.6bn
jpcrp040300-q2r_E00703-000Devicesreportable segmentsegment profit2021-04-01 → 2021-06-30¥4.7bn
jpcrp040300-q2r_E00703-000Industrial Materialsreportable segmentsegment profit2021-01-01 → 2021-06-30¥2.8bn
jpcrp040300-q2r_E00703-000Industrial Materialsreportable segmentsegment profit2021-04-01 → 2021-06-30¥1.6bn
jpcrp040300-q2r_E00703-000Medical Technologiesreportable segmentsegment profit2021-01-01 → 2021-06-30¥487m
jpcrp040300-q2r_E00703-000Medical Technologiesreportable segmentsegment profit2021-04-01 → 2021-06-30¥209m
—segment totalsegment profit2021-01-01 → 2021-06-30¥11.9bn
—segment totalsegment profit2021-04-01 → 2021-06-30¥6.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-01-01 → 2021-06-30¥11.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-06-30¥6.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 942
ItemContextValueUnit
Net increase decrease in cash and cash equivalents IFRSPrior1YTDDuration6801000000JPY
Net increase decrease in cash and cash equivalents IFRSCurrentYTDDuration2698000000JPY
Cash and cash equivalents if different from bs balance IFRSPrior2YearInstant25067000000JPY
Cash and cash equivalents if different from bs balance IFRSPrior1YearInstant42330000000JPY
Cash and cash equivalents IFRSPrior1QuarterInstant31868000000JPY
Cash and cash equivalents IFRSCurrentQuarterInstant45028000000JPY
Sales to external customers IFRSPrior1YTDDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember29885000000JPY
Sales to external customers IFRSPrior1YTDDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember52516000000JPY
Sales to external customers IFRSPrior1YTDDuration_jpcrp040300-q2r_E00703-000MedicalTechnologiesReportableSegmentMember11510000000JPY
Sales to external customers IFRSPrior1YTDDuration_ReportableSegmentsMember93912000000JPY
Sales to external customers IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember3672000000JPY
Sales to external customers IFRSPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember97584000000JPY
Sales to external customers IFRSPrior1YTDDuration_ReconcilingItemsMember－JPY
Sales to external customers IFRSPrior1YTDDuration97584000000JPY
Intersegment sales IFRSPrior1YTDDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember483000000JPY
Intersegment sales IFRSPrior1YTDDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember5000000JPY
Intersegment sales IFRSPrior1YTDDuration_jpcrp040300-q2r_E00703-000MedicalTechnologiesReportableSegmentMember－JPY
Intersegment sales IFRSPrior1YTDDuration_ReportableSegmentsMember489000000JPY
Intersegment sales IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember682000000JPY
Intersegment sales IFRSPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember1171000000JPY
Intersegment sales IFRSPrior1YTDDuration_ReconcilingItemsMember-1171000000JPY
Intersegment sales IFRSPrior1YTDDuration－JPY
Net sales IFRSPrior1YTDDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember30369000000JPY
Net sales IFRSPrior1YTDDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember52521000000JPY
Net sales IFRSPrior1YTDDuration_jpcrp040300-q2r_E00703-000MedicalTechnologiesReportableSegmentMember11510000000JPY
Net sales IFRSPrior1YTDDuration_ReportableSegmentsMember94401000000JPY
Net sales IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember4354000000JPY
Net sales IFRSPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember98755000000JPY
Net sales IFRSPrior1YTDDuration_ReconcilingItemsMember-1171000000JPY
Net sales IFRSPrior1YTDDuration97584000000JPY
Operating profit loss IFRSPrior1YTDDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember2784000000JPY
Operating profit loss IFRSPrior1YTDDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember8598000000JPY
Operating profit loss IFRSPrior1YTDDuration_jpcrp040300-q2r_E00703-000MedicalTechnologiesReportableSegmentMember487000000JPY
Operating profit loss IFRSPrior1YTDDuration_ReportableSegmentsMember11869000000JPY
Operating profit loss IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-538000000JPY
Operating profit loss IFRSPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember11331000000JPY
Operating profit loss IFRSPrior1YTDDuration_ReconcilingItemsMember-474000000JPY
Operating profit loss IFRSPrior1YTDDuration10857000000JPY
Finance income IFRSPrior1YTDDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember－JPY
Finance income IFRSPrior1YTDDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember－JPY
Finance income IFRSPrior1YTDDuration_jpcrp040300-q2r_E00703-000MedicalTechnologiesReportableSegmentMember－JPY
Finance income IFRSPrior1YTDDuration_ReportableSegmentsMember－JPY
Finance income IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Finance income IFRSPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember－JPY
Finance income IFRSPrior1YTDDuration_ReconcilingItemsMember－JPY
Finance income IFRSPrior1YTDDuration1890000000JPY
Finance costs IFRSPrior1YTDDuration_jpcrp040300-q2r_E00703-000IndustrialMaterialsReportableSegmentMember－JPY
Finance costs IFRSPrior1YTDDuration_jpcrp040300-q2r_E00703-000DevicesReportableSegmentMember－JPY
Finance costs IFRSPrior1YTDDuration_jpcrp040300-q2r_E00703-000MedicalTechnologiesReportableSegmentMember－JPY
Finance costs IFRSPrior1YTDDuration_ReportableSegmentsMember－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2021-12-31pass
balance sheet identityconsolidated 2022-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-01-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2021-01-01/2021-06-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2021-12-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass